CIK 2010850
Decheng Capital LLC
Institutional 13F holdings & portfolio
Holdings
19
Portfolio Value
$1M+
Latest Report
Dec 31, 2025
Report Periods
1
Holdings
13F filings as of Dec 31, 2025 · Showing 1–19 of 19
| Ticker | Company | Shares | Value | Type |
|---|---|---|---|---|
| CGON | CG ONCOLOGY INC | 6.4M | $1M+ | SH |
| NUVB | Nuvation Bio Inc. | 26.0M | $1M+ | SH |
| UPB | Upstream Bio Inc. | 3.1M | $1M+ | SH |
| AARD | AARDVARK THERAPEUTICS INC | 3.9M | $1M+ | SH |
| LYEL | Lyell Immunopharma, Inc. | 692K | $1M+ | SH |
| NAMS | NEWAMSTERDAM PHARMA CO NV | 592K | $1M+ | SH |
| RVMD | REVOLUTION MEDICINES INC(NSM) | 200K | $1M+ | SH |
| RCUS | Arcus Biosciences, Inc | 542K | $1M+ | SH |
| ACRS | Aclaris Therapeutics, Inc. | 4.0M | $1M+ | SH |
| EQ | Equillium Inc. | 4.4M | $1M+ | SH |
| BYSI | BeyondSpring Inc. | 3.8M | $1M+ | SH |
| CRNX | CRINETICS PHARMACEUTICALS IN | 93K | $1M+ | SH |
| KRYS | KRYSTAL BIOTECH INC | 17K | $1M+ | SH |
| AURA | Aura Biosciences, Inc. | 360K | $1M+ | SH |
| ZNTL | Zentalis Pharmaceuticals Inc. | 1.3M | $1M+ | SH |
| PYXS | Pyxis Oncology, Inc (formerly Apexigen) | 327K | $100K–$500K | SH |
| FDMT | 4D MOLECULAR THERAPEUTICS IN | 44K | $100K–$500K | SH |
| NUVB.WS | Nuvation Bio Inc. | 646K | $100K–$500K | SH |
| RZLT | REZOLUTE INC | 60K | $100K–$500K | SH |